All news articles for January 2013

DMAA blamed for London marathon death

DMAA in the dock

DMAA blamed for London marathon death

By Shane STARLING

A single dose of the banned stimulant DMAA was the most probable cause of the heart attack that killed Claire Squires in hospital after she collapsed during the final metres of the 2012 London marathon.

Packaging helps drive success in point-of-purchase marketplace

Packaging helps drive success in point-of-purchase marketplace

By Hank Schultz

When entrepreneur Tyler Johansen was launching a supplement designed to help boost students’ concentration, he decided to play in a sphere where snap decisions are made, at the edge of the counter in the point-of-purchase marketplace.

NSF expands in Latin America with Peruvian acquisition

NSF expands in Latin America with Peruvian acquisition

By Hank Schultz

NSF International announced a significant expansion of its footprint in Latin America with the acquisition of INASSA Group of Lima, Peru.  INASSA provides technical analysis, laboratory and sanitation services. In particular, the move means NSF will be...

Cost and supply benefits are 'icing on the cake' for soy proteins

Special edition: Protein-rich foods: The next generation

Cost and supply benefits are 'icing on the cake' for soy proteins

By Stephen DANIELLS

After a few years of difficult market conditions, the soy protein market is enjoying ‘dynamic growth’, but what does the future hold for this ingredient, and what kind of impact will the GMO issue have?

GRAS status will boost benfotiamine, XSTO says

GRAS status will boost benfotiamine, XSTO says

By Hank Schultz

Benfotiamine, a form of thiamine or vitamin B1, has been on the market for decades.  So what makes BenfoPure, a branded form of the ingredient now represented by XSTO Solutions, special? The differentiator, said XSTO’s Dan Murray, is in the details.

Lutein pills may boost night vision: RCT

Lutein pills may boost night vision: RCT

By Stephen DANIELLS

Daily supplements of lutein may improve vision and help with tasks such as driving at night, say data from a randomized, double-blind, placebo-controlled trial.

US pea protein market ‘ready to explode’

Special edition: Protein-rich foods: The next generation

US pea protein market ‘ready to explode’

By Stephen DANIELLS

For a long time in the shadow of soy as a plant protein source, pea protein is establishing itself in food and beverage applications, with the US market set to explode, say industry experts.

Kyowa Hakko benefits from Champion Sports' strategic shift

Kyowa Hakko benefits from Champion Sports' strategic shift

By Hank Schultz

The recent boost in sports nutrition product launches is benefiting functional food ingredient suppliers, among them Kyowa Hakko, whose Sustamine ingredient is featured in a new beverage offering from Champion Nutrition.

Zinc to benefit from health claims game

Special edition: Innovations in minerals

Zinc benefitting from EU health claims game

By Shane Starling

Used in cigarette filters, as a corrosive, pigment and in the manufacture of rubber and concrete, zinc forms like zinc oxide and zinc suphate are also important nutrients for physiological wellbeing. And 18 new European Union health claims – the most...

Will 'metabesity' supercede 'diabesity' in metabolic syndrome marketing?

Will 'metabesity' supercede 'diabesity' in metabolic syndrome marketing?

By Hank Schultz

As waistlines around the globe continue to swell, researchers and marketers struggle to find a rhetorical way to get their hands around the problem.  First there was obesity, which became “diabesity,” adding diabetes to the mix.  The latest entrant in...

Are vitamin D levels linked to mental health?

Are vitamin D levels linked to mental health?

By Stephen Daniells

Low levels of vitamin D may be associated with an increased risk of depression in mid-life, says a new study from University College London in the UK.

USPLabs sets aside $2m to settle DMAA class action cases

USPLabs sets aside $2m to settle DMAA class action cases

By Elaine WATSON

After a tidal wave of lawsuits and months of heated debate about the regulatory status of the stimulant DMAA (1,3-Dimethylamylamine), USPLabs has agreed to settle a nationwide class action suit challenging the legality and safety of its top-selling DMAA...

Follow us

Products

View more

Webinars